RPMO₂ features a fully embedded oximeter over maxillary dentition, using buccal vestibule mucosa behind the upper lip.
Travere Therapeutics has received the US Food and Drug Administration (FDA) full approval for Filspari (sparsentan) to reduce ...
Sparsentan received full FDA approval for FSGS in patients aged 8–75 years, addressing a rare, progressive glomerulopathy ...
ProSomnus Sleep Technologies has announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results